The latest quarterly R&D expense is $30.59 Million with a QoQ Growth of +7.63%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2027 (2026-07-31).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2027 (2026-07-31): $30.59M.
$30.59M
$30.59 Million
Q2 FY2027 · 2026-07-31
+7.63%
vs. $28.42M prior quarter
30
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2027Period end 2026-07-31 | $30.59M | +7.63% | -11.75% |
| Q1 FY2027Period end 2026-04-30 | $28.42M | -5.19% | -14.75% |
| Q4 FY2026Period end 2026-01-31 | $29.98M | +1.48% | -6.70% |
| Q3 FY2026Period end 2025-10-31 | $29.54M | -14.79% | -10.59% |
| Q2 FY2026Period end 2025-07-31 | $34.67M | +3.98% | +1.16% |
| Q1 FY2026Period end 2025-04-30 | $33.34M | +3.77% | +11.21% |
| Q4 FY2025Period end 2025-01-31 | $32.13M | -2.75% | +6.45% |
| Q3 FY2025Period end 2024-10-31 | $33.04M | -3.59% | +13.76% |
| Q2 FY2025Period end 2024-07-31 | $34.27M | +14.31% | +14.66% |
| Q1 FY2025Period end 2024-04-30 | $29.98M | -0.67% | +6.33% |
| Q4 FY2024Period end 2024-01-31 | $30.18M | +3.93% | -9.33% |
| Q3 FY2024Period end 2023-10-31 | $29.04M | -2.83% | -1.45% |
| Q2 FY2024Period end 2023-07-31 | $29.89M | +6.01% | +0.63% |
| Q1 FY2024Period end 2023-04-30 | $28.20M | -15.30% | -3.16% |
| Q4 FY2023Period end 2023-01-31 | $33.29M | +12.96% | +42.43% |
| Q3 FY2023Period end 2022-10-31 | $29.47M | -0.77% | +47.68% |
| Q2 FY2023Period end 2022-07-31 | $29.70M | +2.01% | +59.61% |
| Q1 FY2023Period end 2022-04-30 | $29.11M | +24.57% | +67.09% |
| Q4 FY2022Period end 2022-01-31 | $23.37M | +17.12% | +38.06% |
| Q3 FY2022Period end 2021-10-31 | $19.96M | +7.24% | +32.36% |
| Q2 FY2022Period end 2021-07-31 | $18.61M | +6.79% | +21.69% |
| Q1 FY2022Period end 2021-04-30 | $17.43M | +2.93% | +58.91% |
| Q4 FY2021Period end 2021-01-31 | $16.93M | +12.28% | +67.08% |
| Q3 FY2021Period end 2020-10-31 | $15.08M | -1.41% | +58.14% |
| Q2 FY2021Period end 2020-07-31 | $15.29M | +39.46% | +84.86% |
| Q1 FY2021Period end 2020-04-30 | $10.96M | +8.22% | +48.86% |
| Q4 FY2020Period end 2020-01-31 | $10.13M | +6.27% | N/A |
| Q3 FY2020Period end 2019-10-31 | $9.53M | +15.26% | N/A |
| Q2 FY2020Period end 2019-07-31 | $8.27M | +12.30% | N/A |
| Q1 FY2020Period end 2019-04-30 | $7.37M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
